Seropositive spondyloarthropathic disorders (obj 22) Flashcards

1
Q

thickening of skin confined to face, neck, and distal extremities

A

scleroderma (limited) - 80% of cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

widespread thickening of skin, including truncal involvement, with areas of increased pigmentation & depigmentation

A

scleroderma (diffuse) - 20% of cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

these 2 things are present in virtually all scleroderma patients

A

Raynaud phenomenon

positive ANA test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

another name for limited scleroderma

A

CREST syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CREST syndrome is:

A
Calcinosis cutis
Raynaud phenomenon
Esophageal motility disorder
Sclerodactyly
Telangiectasia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

dryness of the eyes and dry mouth (sicca components) are the most common features of this disease

A

Sjögren syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Sjögren syndrome is usually associated with ____ but could occur with SLE, scleroderma, etc.

A

Rheumatoid arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

These two lab tests are probably positive in Sjögren syndrome

A

RF

ANA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

This test measures the quantity of tears secreted, and therefore could be useful in diagnosing Sjögren syndrome

A

Schirmer test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

bilateral gradual, progressive muscle weakness of proximal upper and lower extremities as well as neck

A

polymyositis, dermatomyositis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How can polymyositis/dermatomyositis be differentiated from myasthenia gravis?

A

facial/ocular weakness!

polymyositis/dermatomyositis: NO; myasthenia gravis yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What differentiates the dysphagias of scleroderma and polymyositis/dermatomyositis?

A

~scleroderma: affects smooth muscle of lower esophagus, causing a “sticking” sensation below sternum
~poly/dermato: affects striated muscles of upper pharynx, making initiation of swallowing difficult

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are THREE characteristic rashes of dermatomyositis?

A
  1. dusky red, malar distribution
  2. heliotrope (violaceous periorbital edema)
  3. shawl sign (erythema over neck, shoulders, upper chest/back)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the hands of someone with dermatomyositis.

A

Gottron sign! (scaly red patches over the dorsum of the PIP and MCP joints)

–also periungual erythema and dilations of nailbed capillaries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The only specific diagnostic test for polymyositis/dermatomyositis:

A

muscle biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The 2 different muscle biopsy findings for poly and dermato myositis

A

polymyositis: endomysial infiltration
dermatomyositis: perifascicular atrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

treatment for polymyositis/dermatomyositis

A

corticosteroids

18
Q

hypercoagulability with recurrent thromboses

A

antiphospholipid syndrome

19
Q

With antiphospholipid syndrome, thromboses occur in (venous, arterial) circulation

A

EITHER

20
Q

If your patient has three or more unexplained miscarriages during the first trimester, you may suspect:

A

antiphospholipid syndrome

21
Q

treatment for antiphospholipid syndrome

A

lifelong anticoagulation with warfarin

heparin + aspirin if pregnant

22
Q

Patients with ____ or _____ have an increased risk of malignancy.

A

Dermatomyositis

SLE

23
Q

Many of the clinical manifestations of this disease are due to the trapping of antigen-antibody complexes in capillaries of viscera OR due to autoimmune destruction of host cells

A

Systemic lupus erythematosus (SLE)

24
Q

This demographic group tends to get SLE.

A

Young black women

25
Q

Before making a diagnosis of SLE, it is important to ascertain that the condition is not due to _____.

A

DRUGS

26
Q

This test is sensitive but not specific for SLE.

A

ANA

positive in virtually all patients with SLE but also positive in other conditions (e.g. scleroderma, Sjögren syndrome)

27
Q

What is the rash usually thought of as characteristic of SLE?

A

malar (butterfly) rash on face

28
Q

Over 90% of patients with SLE have this clinical manifestation, which is often the earliest manifestation.

A

joint symptoms

29
Q

What are 3 major sources of disease morbidity in SLE?

A
  1. glomerulonephritis
  2. CNS disease
  3. antiphospholipid antibodies
30
Q

SLE patient education: patients with SLE must be cautioned against exposure to what?

A

SUN

31
Q

Treatments for SLE:

A

~NSAIDs (for joint pain)
~corticosteroids (for skin lesions, glomerulonephritis, CNS problems, etc.)
~antimalarials (for lupus rashes, joint symptoms)
~immunosuppressive agents

32
Q

Symmetric polyarthritis in small joints of hands and feet

A

Rheumatoid arthritis

33
Q

What is the most specific blood test for rheumatoid arthritis?

A

Anti-CCP antibodies

34
Q

Radiographic changes seen in rheumatoid arthritis are:

A
  1. joint space narrowing

2. joint erosion

35
Q

Compare and contrast rheumatoid arthritis and osteoarthritis. (3)

A

Osteoarthritis spares the wrist and MCP joints.
Osteoarthritis joint pain is relieved by rest.
Osteoarthritis has minimal articular inflammation.

36
Q

As soon as you confirm your diagnosis of RA, you should start what treatment?

A

DMARDs

disease-modifying anti-rheumatic drugs

37
Q

Name one synthetic DMARD and one biologic DMARD.

A

synthetic: methotrexate
biologic: TNF inhibitors

38
Q

What is the role of corticosteroids in the treatment of RA?

A

Corticosteroids have a PROMPT anti-inflammatory effect, and are often used as a “bridge” to reduce disease activity until the slower-acting DMARDs take effect (or as adjunctive therapy for disease that persists despite treatment with DMARDs).

39
Q

Why would you give ACE inhibitors for SLE?

A

renal disease/BP control

40
Q

Smith autoantibody

A

SLE